Gastroenterology, ISSN 0016-5085, 04/2017, Volume 152, Issue 5, pp. S1244 - S1244
Journal Article
Gastroenterology, ISSN 0016-5085, 04/2017, Volume 152, Issue 5, pp. S1285 - S1285
Journal Article
Gastroenterology, ISSN 0016-5085, 2017, Volume 152, Issue 5, pp. S1285 - S1285
Journal Article
Journal of Surgical Oncology, ISSN 0022-4790, 12/2016, Volume 114, Issue 8, pp. 947 - 950
Journal Article
Journal of Clinical Oncology, ISSN 0732-183X, 10/2013, Volume 31, Issue 28, pp. 3608 - 3608
Journal Article
Journal of Surgical Oncology, ISSN 0022-4790, 12/2014, Volume 110, Issue 8, pp. 970 - 975
Journal Article
Annals of Surgery, ISSN 0003-4932, 08/2007, Volume 246, Issue 2, pp. 246 - 253
Objective: To analyze in-hospital mortality after pancreatectomy using a large national database. Summary and Background Data: Pancreatic resections, including...
PANCREATICODUODENECTOMY | SURVIVAL | SURGERY | OPERATIVE MORTALITY | DISTAL PANCREATECTOMY | MORBIDITY | CANCER-SURGERY | RESECTION | ADENOCARCINOMA | VOLUME | IN-HOSPITAL MORTALITY | Multivariate Analysis | United States - epidemiology | Age Distribution | Survival Rate - trends | Humans | Middle Aged | Pancreatic Neoplasms - surgery | Risk Factors | Postoperative Period | Male | Treatment Outcome | Pancreatectomy - mortality | Hospital Mortality - trends | Adolescent | Aged, 80 and over | Sex Distribution | Adult | Female | Aged | Pancreatic Neoplasms - mortality | Retrospective Studies | Odds Ratio | Pancreatectomy - methods | Original
PANCREATICODUODENECTOMY | SURVIVAL | SURGERY | OPERATIVE MORTALITY | DISTAL PANCREATECTOMY | MORBIDITY | CANCER-SURGERY | RESECTION | ADENOCARCINOMA | VOLUME | IN-HOSPITAL MORTALITY | Multivariate Analysis | United States - epidemiology | Age Distribution | Survival Rate - trends | Humans | Middle Aged | Pancreatic Neoplasms - surgery | Risk Factors | Postoperative Period | Male | Treatment Outcome | Pancreatectomy - mortality | Hospital Mortality - trends | Adolescent | Aged, 80 and over | Sex Distribution | Adult | Female | Aged | Pancreatic Neoplasms - mortality | Retrospective Studies | Odds Ratio | Pancreatectomy - methods | Original
Journal Article
Cancer, ISSN 0008-543X, 02/2009, Volume 115, Issue 4, pp. 741 - 751
BACKGROUND: Although surgical resection is generally recommended for patients with localized pancreatic neuroendocrine tumors (PNETs), the impact of resection...
pancreatic neuroendocrine tumors | database | Surveillance | End Results (SEER) | Epidemiology | pancreatic resection | survival advantage | Survival advantage | Pancreatic neuroendocrine tumors | End results (seer) database | Pancreatic resection | SURVIVAL | POPULATION | ISLET-CELL CARCINOMA | RESECTION | End Results (SEER) database | ZOLLINGER-ELLISON-SYNDROME | SURGICAL-TREATMENT | HEPATIC METASTASES | ONCOLOGY | AGGRESSIVE SURGERY | LIVER | EXPERIENCE
pancreatic neuroendocrine tumors | database | Surveillance | End Results (SEER) | Epidemiology | pancreatic resection | survival advantage | Survival advantage | Pancreatic neuroendocrine tumors | End results (seer) database | Pancreatic resection | SURVIVAL | POPULATION | ISLET-CELL CARCINOMA | RESECTION | End Results (SEER) database | ZOLLINGER-ELLISON-SYNDROME | SURGICAL-TREATMENT | HEPATIC METASTASES | ONCOLOGY | AGGRESSIVE SURGERY | LIVER | EXPERIENCE
Journal Article
Gastroenterology, ISSN 0016-5085, 2017, Volume 152, Issue 5, pp. S1244 - S1244
Journal Article
Gastroenterology, ISSN 0016-5085, 2009, Volume 136, Issue 5, pp. A-917 - A-917
Journal Article
Journal of Gastrointestinal Surgery, ISSN 1091-255X, 09/2009, Volume 13, Issue 10, pp. 1798 - 1805
Introduction National studies on in-hospital pancreatic outcomes have focused on mortality. Non-fatal morbidity affects a greater proportion of patients....
Morbidity | Pancreatectomy | Nationwide inpatient sample | PANCREATICODUODENECTOMY | SURVIVAL | SURGERY | ADMINISTRATIVE DATA | VALIDATION | CANCER | EXPERIENCE | OUTCOMES | GASTROENTEROLOGY & HEPATOLOGY | RESECTIONS | Pancreatectomy - adverse effects | United States - epidemiology | Hospital Mortality | Digestive System Diseases - surgery | Humans | Middle Aged | Risk Factors | Male | Pancreatectomy - statistics & numerical data | Postoperative Complications - epidemiology | Pancreatectomy - mortality | Time Factors | Patient Discharge - statistics & numerical data | Female | Length of Stay - statistics & numerical data | Databases, Factual | Confidence intervals | Mortality | Heart attacks
Morbidity | Pancreatectomy | Nationwide inpatient sample | PANCREATICODUODENECTOMY | SURVIVAL | SURGERY | ADMINISTRATIVE DATA | VALIDATION | CANCER | EXPERIENCE | OUTCOMES | GASTROENTEROLOGY & HEPATOLOGY | RESECTIONS | Pancreatectomy - adverse effects | United States - epidemiology | Hospital Mortality | Digestive System Diseases - surgery | Humans | Middle Aged | Risk Factors | Male | Pancreatectomy - statistics & numerical data | Postoperative Complications - epidemiology | Pancreatectomy - mortality | Time Factors | Patient Discharge - statistics & numerical data | Female | Length of Stay - statistics & numerical data | Databases, Factual | Confidence intervals | Mortality | Heart attacks
Journal Article
Cancer Epidemiology Biomarkers & Prevention, ISSN 1055-9965, 07/2008, Volume 17, Issue 7, pp. 1648 - 1652
Pancreatic adenocarcinoma is one of the leading causes of cancer-related deaths in the United States. Sp1 is a sequence-specific DNA binding protein that is...
biomarker | Sp1 | Pancreatic ductal adenocarcinoma | TRANSCRIPTION FACTORS | FACTOR FAMILY | PUBLIC, ENVIRONMENTAL & OCCUPATIONAL HEALTH | METASTASIS | THERAPY | CANCER CELLS | ONCOLOGY | INHIBITOR | EXPRESSION | CARCINOMA | MODULATION | ENDOTHELIAL GROWTH-FACTOR | Immunohistochemistry | Severity of Illness Index | Pancreatic Neoplasms - metabolism | Prognosis | Survival Rate - trends | Follow-Up Studies | Humans | Pancreatic Neoplasms - pathology | Carcinoma, Pancreatic Ductal - metabolism | Male | Carcinoma, Pancreatic Ductal - pathology | Massachusetts - epidemiology | Sp1 Transcription Factor - biosynthesis | Carcinoma, Pancreatic Ductal - genetics | Female | Aged | Pancreatic Neoplasms - mortality | Retrospective Studies | Neoplasm Staging | Biomarkers, Tumor - biosynthesis
biomarker | Sp1 | Pancreatic ductal adenocarcinoma | TRANSCRIPTION FACTORS | FACTOR FAMILY | PUBLIC, ENVIRONMENTAL & OCCUPATIONAL HEALTH | METASTASIS | THERAPY | CANCER CELLS | ONCOLOGY | INHIBITOR | EXPRESSION | CARCINOMA | MODULATION | ENDOTHELIAL GROWTH-FACTOR | Immunohistochemistry | Severity of Illness Index | Pancreatic Neoplasms - metabolism | Prognosis | Survival Rate - trends | Follow-Up Studies | Humans | Pancreatic Neoplasms - pathology | Carcinoma, Pancreatic Ductal - metabolism | Male | Carcinoma, Pancreatic Ductal - pathology | Massachusetts - epidemiology | Sp1 Transcription Factor - biosynthesis | Carcinoma, Pancreatic Ductal - genetics | Female | Aged | Pancreatic Neoplasms - mortality | Retrospective Studies | Neoplasm Staging | Biomarkers, Tumor - biosynthesis
Journal Article
Practical Radiation Oncology, ISSN 1879-8500, 01/2013, Volume 3, Issue 1, pp. 40 - 44
Journal Article
Journal of Clinical Oncology, ISSN 0732-183X, 03/2013, Volume 31, Issue 9, pp. 1130 - 1133
CELL LUNG-CANCER | SURVIVAL | METAANALYSIS | PRIMARY BREAST-CANCER | ONCOLOGY | COLORECTAL-CANCER | PANCREATIC-CANCER | SURVEILLANCE | RANDOMIZED-TRIAL | UPDATE | CHEMOTHERAPY | Breast Neoplasms - surgery | Colorectal Neoplasms - surgery | Carcinoma, Non-Small-Cell Lung - surgery | Follow-Up Studies | Neoplasms - surgery | Humans | Pancreatic Neoplasms - surgery | Female
Journal Article
15.
Full Text
A Simple Risk Score to Predict In-Hospital Mortality After Pancreatic Resection for Cancer
Annals of Surgical Oncology, ISSN 1068-9265, 7/2010, Volume 17, Issue 7, pp. 1802 - 1807
Pancreatectomy for cancer continues to have substantial perioperative risk, and the factors affecting mortality are ill defined. An integer-based risk score...
Oncology | Medicine & Public Health | Surgical Oncology | Surgery | SURGERY | MORBIDITY | ONCOLOGY | ADENOCARCINOMA | Risk Assessment | Comorbidity | Humans | Middle Aged | Pancreatic Neoplasms - surgery | Risk Factors | Pancreatectomy | Male | Survival Rate | Treatment Outcome | Hospital Mortality - trends | Inpatients | Aged, 80 and over | Female | Aged | Pancreatic Neoplasms - mortality | Cohort Studies | Medical colleges | Usage | Prognosis | Pancreatic cancer | Patient outcomes | Mortality | Risk factors
Oncology | Medicine & Public Health | Surgical Oncology | Surgery | SURGERY | MORBIDITY | ONCOLOGY | ADENOCARCINOMA | Risk Assessment | Comorbidity | Humans | Middle Aged | Pancreatic Neoplasms - surgery | Risk Factors | Pancreatectomy | Male | Survival Rate | Treatment Outcome | Hospital Mortality - trends | Inpatients | Aged, 80 and over | Female | Aged | Pancreatic Neoplasms - mortality | Cohort Studies | Medical colleges | Usage | Prognosis | Pancreatic cancer | Patient outcomes | Mortality | Risk factors
Journal Article
Surgical Endoscopy, ISSN 0930-2794, 2010, Volume 24, Issue 10, pp. 2518 - 2526
Background Adrenalectomy remains the definitive therapy for most adrenal neoplasms. Introduced in the 1990s, laparoscopic adrenalectomy is reported to have...
Adrenalectomy | Nationwide inpatient sample | Complications | Mortality | SURGERY | LEARNING-CURVE | LAPAROSCOPIC ADRENALECTOMY | MORBIDITY | EXPERIENCE | OUTCOMES | OPEN POSTERIOR ADRENALECTOMY | Adrenal Gland Neoplasms - surgery | Hospital Mortality | United States | Adrenalectomy - adverse effects | Humans | Middle Aged | Laparoscopy - trends | Male | Laparoscopy - statistics & numerical data | Adrenalectomy - mortality | Adrenalectomy - statistics & numerical data | Adrenalectomy - trends | Female | Laparoscopic surgery | Laparoscopy | Comorbidity | Health aspects | Analysis
Adrenalectomy | Nationwide inpatient sample | Complications | Mortality | SURGERY | LEARNING-CURVE | LAPAROSCOPIC ADRENALECTOMY | MORBIDITY | EXPERIENCE | OUTCOMES | OPEN POSTERIOR ADRENALECTOMY | Adrenal Gland Neoplasms - surgery | Hospital Mortality | United States | Adrenalectomy - adverse effects | Humans | Middle Aged | Laparoscopy - trends | Male | Laparoscopy - statistics & numerical data | Adrenalectomy - mortality | Adrenalectomy - statistics & numerical data | Adrenalectomy - trends | Female | Laparoscopic surgery | Laparoscopy | Comorbidity | Health aspects | Analysis
Journal Article
Annals of Surgery, ISSN 0003-4932, 01/2019, Volume 269, Issue 1, pp. 48 - 52
BACKGROUND:Our previous case series suggested that a 1-week, low-calorie and low-fat diet was associated with decreased intraoperative blood loss in patients...
ACUTE NORMOVOLEMIC HEMODILUTION | SURGERY | FIBRIN SEALANT PATCH | bleeding | CLINICAL-TRIAL | BLOOD-LOSS | liver maneuverability | PRINGLE MANEUVER | WEIGHT-LOSS | liver surgery | hepatic glycogen | HEPATIC RESECTION | hepatectomy | very low-calorie diet | RISK-FACTOR | LIVER RESECTION | LOW-ENERGY DIET | steatosis | liver manipulation | Complications and side effects | Usage | Control | Analysis | Clinical trials | Preoperative care | Hemorrhage | Hepatectomy
ACUTE NORMOVOLEMIC HEMODILUTION | SURGERY | FIBRIN SEALANT PATCH | bleeding | CLINICAL-TRIAL | BLOOD-LOSS | liver maneuverability | PRINGLE MANEUVER | WEIGHT-LOSS | liver surgery | hepatic glycogen | HEPATIC RESECTION | hepatectomy | very low-calorie diet | RISK-FACTOR | LIVER RESECTION | LOW-ENERGY DIET | steatosis | liver manipulation | Complications and side effects | Usage | Control | Analysis | Clinical trials | Preoperative care | Hemorrhage | Hepatectomy
Journal Article
Journal of Surgical Oncology, ISSN 0022-4790, 12/2016, Volume 114, Issue 8, pp. 947 - 950
Background and Objectives Lymphatic mapping (LM) and blue dye injections are essential to identification of sentinel lymph nodes (SLN) for melanoma. LM is...
lymphatic metastasis | sentinel lymph node biopsy | radiometry | BREAST-CANCER | SURGERY | ISOSULFAN BLUE | ONCOLOGY | CLINICAL-PRACTICE GUIDELINE | LYMPHAZURIN | AMERICAN SOCIETY | Skin Neoplasms - pathology | Skin Neoplasms - diagnostic imaging | Melanoma - diagnostic imaging | Outcome Assessment (Health Care) | Coloring Agents | Humans | Middle Aged | Sentinel Lymph Node Biopsy - methods | Male | Sentinel Lymph Node - diagnostic imaging | Lymphatic Metastasis | Melanoma - pathology | Sentinel Lymph Node - pathology | Sentinel Lymph Node - surgery | Adult | Female | Methylene Blue | Aged | Retrospective Studies | Melanoma - surgery | Lymphoscintigraphy | Skin Neoplasms - surgery | Preoperative Care - methods | Melanoma
lymphatic metastasis | sentinel lymph node biopsy | radiometry | BREAST-CANCER | SURGERY | ISOSULFAN BLUE | ONCOLOGY | CLINICAL-PRACTICE GUIDELINE | LYMPHAZURIN | AMERICAN SOCIETY | Skin Neoplasms - pathology | Skin Neoplasms - diagnostic imaging | Melanoma - diagnostic imaging | Outcome Assessment (Health Care) | Coloring Agents | Humans | Middle Aged | Sentinel Lymph Node Biopsy - methods | Male | Sentinel Lymph Node - diagnostic imaging | Lymphatic Metastasis | Melanoma - pathology | Sentinel Lymph Node - pathology | Sentinel Lymph Node - surgery | Adult | Female | Methylene Blue | Aged | Retrospective Studies | Melanoma - surgery | Lymphoscintigraphy | Skin Neoplasms - surgery | Preoperative Care - methods | Melanoma
Journal Article
HPB, ISSN 1365-182X, 2016, Volume 18, Issue 4, pp. 360 - 366
Abstract Background Long-term incidence of endocrine and exocrine insufficiency after pancreatectomy is poorly described. We analyze the long-term risks of...
Gastroenterology and Hepatology | Islets of Langerhans - drug effects | Humans | Middle Aged | Pancreas, Exocrine - pathology | Male | Islets of Langerhans - surgery | Exocrine Pancreatic Insufficiency - diagnosis | Pancreas, Exocrine - surgery | Pancreas, Exocrine - drug effects | Pancreaticoduodenectomy - adverse effects | Young Adult | Exocrine Pancreatic Insufficiency - physiopathology | Time Factors | Chemotherapy, Adjuvant - adverse effects | Radiotherapy, Adjuvant - adverse effects | Aged, 80 and over | Islets of Langerhans - physiopathology | Adult | Female | Retrospective Studies | Databases, Factual | Hypoglycemic Agents - therapeutic use | Pancreatectomy - adverse effects | Islets of Langerhans - pathology | Exocrine Pancreatic Insufficiency - drug therapy | Pancreatic Neoplasms - pathology | Pancreatic Neoplasms - surgery | Risk Factors | Treatment Outcome | Exocrine Pancreatic Insufficiency - etiology | Aged | Pancreas, Exocrine - physiopathology | Original
Gastroenterology and Hepatology | Islets of Langerhans - drug effects | Humans | Middle Aged | Pancreas, Exocrine - pathology | Male | Islets of Langerhans - surgery | Exocrine Pancreatic Insufficiency - diagnosis | Pancreas, Exocrine - surgery | Pancreas, Exocrine - drug effects | Pancreaticoduodenectomy - adverse effects | Young Adult | Exocrine Pancreatic Insufficiency - physiopathology | Time Factors | Chemotherapy, Adjuvant - adverse effects | Radiotherapy, Adjuvant - adverse effects | Aged, 80 and over | Islets of Langerhans - physiopathology | Adult | Female | Retrospective Studies | Databases, Factual | Hypoglycemic Agents - therapeutic use | Pancreatectomy - adverse effects | Islets of Langerhans - pathology | Exocrine Pancreatic Insufficiency - drug therapy | Pancreatic Neoplasms - pathology | Pancreatic Neoplasms - surgery | Risk Factors | Treatment Outcome | Exocrine Pancreatic Insufficiency - etiology | Aged | Pancreas, Exocrine - physiopathology | Original
Journal Article
Journal of the American College of Surgeons, ISSN 1072-7515, 2016, Volume 223, Issue 4, pp. e140 - e141
Journal Article
No results were found for your search.
Cannot display more than 1000 results, please narrow the terms of your search.